TrumpRx: Comprehensive Overview

On February 5, 2026, the Trump administration launched TrumpRx.gov, offering discounted cash prices on 43 brand-name medications from five pharmaceutical companies, with 11 more companies expected soon. The platform operates under a Most-Favored-Nation (MFN)pricing model—ensuring U.S. consumers pay no more than the lowest prices charged in other wealthy nations. TrumpRx does not sell drugs directly; instead, it provides coupons or links to manufacturers' direct-to-consumer sites.